Intriguingly, despite clear enrichment of DUOX2 and DUOXA2 variants in cohorts with CH, the occurrence of pathogenic variants in these genes in an apparently healthy population (e.g. gnoMAD) is more frequent than compatible with the prevalence of GIS CH. Here, DUOXA2 is linked to cyclic hematopoiesis.